# A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine

> **NCT03554798** · PHASE2 · COMPLETED · sponsor: **Fidec Corporation** · enrollment: 1025 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** nOPV2 (monovalent oral polio vaccine)

## Key facts

- **NCT ID:** NCT03554798
- **Lead sponsor:** Fidec Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-04
- **Primary completion:** 2020-02-19
- **Final completion:** 2020-02-19
- **Target enrollment:** 1025 (ACTUAL)
- **Last updated:** 2024-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03554798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03554798, "A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03554798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*